Frailty-Guided Management of Cardiovascular Disease-From Clinical Trials to Clinical Practice

Dae Hyun Kim; Lily Zhong; Michael W Rich

doi:10.1001/jamacardio.2023.1634

Frailty-Guided Management of Cardiovascular Disease-From Clinical Trials to Clinical Practice

JAMA Cardiol. 2023 Oct 1;8(10):897-898. doi: 10.1001/jamacardio.2023.1634.

Authors

Dae Hyun Kim¹, Lily Zhong², Michael W Rich³

Affiliations

¹ Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts.
² University of Connecticut School of Medicine, Farmington.
³ Division of Cardiology, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri.

PMID: 37647048
PMCID: PMC10805234 (available on 2024-10-01)
DOI: 10.1001/jamacardio.2023.1634

No abstract available

Plain language summary

This Viewpoint discusses pitfalls in measurement and interpretation of post hoc frailty scores and proposes standardized frailty assessment in randomized clinical trials.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Aged
Cardiovascular Diseases*
Frailty*
Geriatric Assessment
Humans
Risk Assessment

Plain language summary

Publication types

MeSH terms

Grants and funding